Literature DB >> 22495733

The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death.

Daniel Westreich1, Stephen R Cole, Jessica G Young, Frank Palella, Phyllis C Tien, Lawrence Kingsley, Stephen J Gange, Miguel A Hernán.   

Abstract

The parametric g-formula can be used to contrast the distribution of potential outcomes under arbitrary treatment regimes. Like g-estimation of structural nested models and inverse probability weighting of marginal structural models, the parametric g-formula can appropriately adjust for measured time-varying confounders that are affected by prior treatment. However, there have been few implementations of the parametric g-formula to date. Here, we apply the parametric g-formula to assess the impact of highly active antiretroviral therapy on time to acquired immune deficiency syndrome (AIDS) or death in two US-based human immunodeficiency virus cohorts including 1498 participants. These participants contributed approximately 7300 person-years of follow-up (49% exposed to highly active antiretroviral therapy) during which 382 events occurred and 259 participants were censored because of dropout. Using the parametric g-formula, we estimated that antiretroviral therapy substantially reduces the hazard of AIDS or death (hazard ratio = 0.55; 95% confidence limits [CL]: 0.42, 0.71). This estimate was similar to one previously reported using a marginal structural model, 0.54 (95% CL: 0.38, 0.78). The 6.5-year difference in risk of AIDS or death was 13% (95% CL: 8%, 18%). Results were robust to assumptions about temporal ordering, and extent of history modeled, for time-varying covariates. The parametric g-formula is a viable alternative to inverse probability weighting of marginal structural models and g-estimation of structural nested models for the analysis of complex longitudinal data.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22495733      PMCID: PMC3641816          DOI: 10.1002/sim.5316

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  29 in total

1.  Estimating causal effects from epidemiological data.

Authors:  Miguel A Hernán; James M Robins
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

2.  Invited commentary: positivity in practice.

Authors:  Daniel Westreich; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2010-02-05       Impact factor: 4.897

3.  Implementation of G-computation on a simulated data set: demonstration of a causal inference technique.

Authors:  Jonathan M Snowden; Sherri Rose; Kathleen M Mortimer
Journal:  Am J Epidemiol       Date:  2011-03-16       Impact factor: 4.897

4.  The control of confounding by intermediate variables.

Authors:  J Robins
Journal:  Stat Med       Date:  1989-06       Impact factor: 2.373

5.  Structural accelerated failure time models for survival analysis in studies with time-varying treatments.

Authors:  Miguel A Hernán; Stephen R Cole; Joseph Margolick; Mardge Cohen; James M Robins
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-07       Impact factor: 2.890

6.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

7.  Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.

Authors:  Stephen R Cole; Miguel A Hernán; Joseph B Margolick; Mardge H Cohen; James M Robins
Journal:  Am J Epidemiol       Date:  2005-08-02       Impact factor: 4.897

8.  Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model.

Authors:  Stephen R Cole; Miguel A Hernán; Kathryn Anastos; Beth D Jamieson; James M Robins
Journal:  Am J Epidemiol       Date:  2007-05-02       Impact factor: 4.897

9.  Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology.

Authors:  Lisa M Bodnar; Marie Davidian; Anna Maria Siega-Riz; Anastasios A Tsiatis
Journal:  Am J Epidemiol       Date:  2004-05-15       Impact factor: 4.897

10.  Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence.

Authors:  Hugo López-Gatell; Stephen R Cole; Joseph B Margolick; Mallory D Witt; Jeremy Martinson; John P Phair; Lisa P Jacobson
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

View more
  60 in total

1.  Imputation approaches for potential outcomes in causal inference.

Authors:  Daniel Westreich; Jessie K Edwards; Stephen R Cole; Robert W Platt; Sunni L Mumford; Enrique F Schisterman
Journal:  Int J Epidemiol       Date:  2015-07-25       Impact factor: 7.196

2.  Generalisability of an online randomised controlled trial: an empirical analysis.

Authors:  Cheng Wang; Katie R Mollan; Michael G Hudgens; Joseph D Tucker; Heping Zheng; Weiming Tang; Li Ling
Journal:  J Epidemiol Community Health       Date:  2017-11-28       Impact factor: 3.710

3.  Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States.

Authors:  Salina P Waddy; Allen J Solomon; Adan Z Becerra; Julia B Ward; Kevin E Chan; Chyng-Wen Fwu; Jenna M Norton; Paul W Eggers; Kevin C Abbott; Paul L Kimmel
Journal:  J Am Soc Nephrol       Date:  2020-02-20       Impact factor: 10.121

4.  Invited commentary: Agent-based models for causal inference—reweighting data and theory in epidemiology.

Authors:  Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2014-12-05       Impact factor: 4.897

5.  Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States.

Authors:  Jessie K Edwards; Stephen R Cole; Daniel Westreich; Michael J Mugavero; Joseph J Eron; Richard D Moore; William C Mathews; Peter Hunt; Carolyn Williams
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

6.  Risk.

Authors:  Stephen R Cole; Michael G Hudgens; M Alan Brookhart; Daniel Westreich
Journal:  Am J Epidemiol       Date:  2015-02-05       Impact factor: 4.897

7.  On the potential of academic epidemiology.

Authors:  Sandro Galea
Journal:  Eur J Epidemiol       Date:  2017-03       Impact factor: 8.082

8.  An introduction to g methods.

Authors:  Ashley I Naimi; Stephen R Cole; Edward H Kennedy
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

9.  Causal inference on electronic health records to assess blood pressure treatment targets: an application of the parametric g formula.

Authors:  Kipp W Johnson; Benjamin S Glicksberg; Rachel A Hodos; Khader Shameer; Joel T Dudley
Journal:  Pac Symp Biocomput       Date:  2018

10.  Commentary: The Limits of Risk Factors Revisited: Is It Time for a Causal Architecture Approach?

Authors:  Katherine M Keyes; Sandro Galea
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.